192 related articles for article (PubMed ID: 4740236)
1. [Therapy of peripheral arterial circulation disorders using 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191)].
Denck H
Arzneimittelforschung; 1973 Apr; 23(4):571-3. PubMed ID: 4740236
[No Abstract] [Full Text] [Related]
2. [Experiences with Trental in peripheral circulatory disorders and cerebrovascular insufficiency (author's transl)].
Schafé MK
Munch Med Wochenschr; 1973 Oct; 115(40):1745-9. PubMed ID: 4801042
[No Abstract] [Full Text] [Related]
3. [Results of a clinical study on the vasodilator 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191)].
Lehrach F; Müller R
Arzneimittelforschung; 1971 Aug; 21(8):1171-4. PubMed ID: 5110012
[No Abstract] [Full Text] [Related]
4. [Treatment of peripheral occlusive vascular disease with pentoxifylin (author's transl)].
Traumann KJ
Med Klin; 1976 Mar; 71(11):465-8. PubMed ID: 1263995
[TBL] [Abstract][Full Text] [Related]
5. [The vasoactivogram in the treatment of peripheral arteriopathies].
Romeo S; Spinella G; Sciacchitanto D
Angiologia; 1975; 27(1):7-25. PubMed ID: 1111377
[No Abstract] [Full Text] [Related]
6. [Intra-arterial infusion therapy in thrombo-obliterating diseases of the lower limbs].
Kurbangaleev SM; Savel'ev IuS
Vestn Khir Im I I Grek; 1974 Oct; 113(10):68-71. PubMed ID: 4432347
[No Abstract] [Full Text] [Related]
7. [Ophthalmological experiences with the xanthine compound BL 191 (author's transl)].
Heinsius E; Flamm P
Med Klin; 1973 Nov; 68(47):1540-8. PubMed ID: 4781096
[No Abstract] [Full Text] [Related]
8. [Therapeutic properties of xanthine nicotinate in the treatment of obliterating arteriopathies].
Tardito E; Azzolini A; De Cristofaro A; Papacharalambus D
Minerva Cardioangiol; 1972; 20(7):369-89. PubMed ID: 5050745
[No Abstract] [Full Text] [Related]
9. [Experiences with a new xanthine derivative in central and peripheral blood circulation disorders].
Hirsch W; Woschée GJ
Ther Ggw; 1971 Nov; 110(11):1668 passim. PubMed ID: 5158649
[No Abstract] [Full Text] [Related]
10. [Drug therapy of arteriosclerotic circulatory disorders].
Nobbe F
Z Allgemeinmed; 1974 Jul; 50(21):957-64. PubMed ID: 4152664
[No Abstract] [Full Text] [Related]
11. The influence of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (pentoxifylline, BL 191) on serum calcium and magnesium levels.
Lossnitzer K; Raptis S; Grebe B; Müller R
Arzneimittelforschung; 1973 Jul; 23(7):938-40. PubMed ID: 4800449
[No Abstract] [Full Text] [Related]
12. [Polygraphic registrations after parenteral administration of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191)].
Jovanović UJ
Arzneimittelforschung; 1972 Jun; 22(6):994-9. PubMed ID: 4559161
[No Abstract] [Full Text] [Related]
13. [Therapy of peripheral obliterating arteriopathies with intra-arterial perfusions of dextran of low molecular weight and vasodilator agents].
Buccellato C; Di Lorenzo GD
Minerva Chir; 1967 Jun; 22(11):692-5. PubMed ID: 6050666
[No Abstract] [Full Text] [Related]
14. [Surheme in chronic obliterative arteriopathies of the lower limbs].
Desruelles J; Waucampt JJ
Lille Med; 1971 Jan; 16():Suppl 1:224-9. PubMed ID: 5162043
[No Abstract] [Full Text] [Related]
15. [Evaluation of delayed-action Tebonin with the study of muscle flow, using xenon 133].
Matteoni R; Reale R; Lauri D; Sirolli C; Tata MV
Minerva Cardioangiol; 1973 Apr; 21(4):264-71. PubMed ID: 4710123
[No Abstract] [Full Text] [Related]
16. [Demonstration of the effect of pentoxyphylline in arterial circulation disorders (double-blind study using Trental 400)].
Schubotz R
Med Welt; 1975 Oct; 26(41):1884-5. PubMed ID: 1196082
[No Abstract] [Full Text] [Related]
17. The use of Xavin infusions in obliterating peripheral arterial disorders.
Keller L; Landi A; Bársony J
Ther Hung; 1975; 23(2):54-9. PubMed ID: 1188703
[No Abstract] [Full Text] [Related]
18. [Pharmacokinetics of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191) in man].
Hinze HJ
Arzneimittelforschung; 1972 Sep; 22(9):1492-5. PubMed ID: 4678611
[No Abstract] [Full Text] [Related]
19. [Intra-arterial treatment of arterial obliterative disease (author's transl)].
Mörl H
Dtsch Med Wochenschr; 1974 Nov; 99(45):2284-6. PubMed ID: 4448136
[No Abstract] [Full Text] [Related]
20. [Effect of 1-(4-oxyphenyl)-1-oxy-2-n-butylaminoethane sulfate on peripheral vascular diseases].
Giulini SM; Agus GB; De Cristoforo A
Minerva Cardioangiol; 1973 Jun; 21(6):434-8. PubMed ID: 4146376
[No Abstract] [Full Text] [Related]
[Next] [New Search]
